Central Region, Central, Singapore The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019. Considering the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Seeds Capital, startups are often financed by Openspace Ventures, Jungle Ventures, Wavemaker Partners. The meaningful sponsors for the fund in investment in the same round are Jungle Ventures, Wavemaker Partners, Heritas Capital Management. In the next rounds fund is usually obtained by RNT Associates, Mitsui & Co, Jungle Ventures.
The overall number of key employees were 2.
Among the most popular portfolio startups of the fund, we may highlight Cialfo, Neuron Mobility, One BioMed. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Automotive, Health Care.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Peptobiotics | $6M | 09 Apr 2024 | Singapore, Central Region, Singapore | ||
Auristone | $4M | 02 Apr 2024 | Singapore, Central Region, Singapore | ||
Prefer | $1M | 22 Feb 2024 | Singapore, Central Region, Singapore | ||
Pyxis | $4M | 30 Jan 2024 | Singapore, Central Region, Singapore | ||
GDMC | $21M | 24 Jan 2024 | Bukit Merah, Central, Singapore | ||
Biorithm | $3M | 18 Dec 2023 | Singapore, Central, Singapore | ||
Meatiply | $3M | 06 Dec 2023 | Singapore, Central Region, Singapore | ||
Entropica Labs | $4M | 07 Nov 2023 | Singapore, Central, Singapore | ||
Engine Biosciences | $27M | 31 Oct 2023 | San Francisco, California, United States |
– Nuevocor has announced the completion of an oversubscribed $24m Series A financing round.
– The round was co-led by EVX Ventures and Boehringer Ingelheim Venture Fund (BIVF), with EDBI, Xora Innovation, SEEDS Capital and other investors joining the syndicate.
– Funds will be used to accelerate the preclinical development of its lead programme, an adeno-associated virus (AAV) – based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the lamin A/C (LMNA) gene.
– Zenyum, a Singapore based direct-to-consumer dental products brand, raised $40m in Series B funding.
– The round was led by L Catterton, which invested invested $25m, with participation from existing investors Sequoia Capital India, RTP Global, Partech, TNB Aura, Seeds Capital, and FEBE Ventures.
– In conjunction with the funding, Anjana Sasidharan, Head of Growth Investments for L Catterton Asia, will be joining Zenyum’s board.
– The company intends to use the funds to accelerate expansion across Asia, deepen its range of products, and further develop its technology stack.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Peptobiotics | $6M | 09 Apr 2024 | Singapore, Central Region, Singapore | ||
Auristone | $4M | 02 Apr 2024 | Singapore, Central Region, Singapore | ||
Prefer | $1M | 22 Feb 2024 | Singapore, Central Region, Singapore | ||
Pyxis | $4M | 30 Jan 2024 | Singapore, Central Region, Singapore | ||
GDMC | $21M | 24 Jan 2024 | Bukit Merah, Central, Singapore | ||
Biorithm | $3M | 18 Dec 2023 | Singapore, Central, Singapore | ||
Meatiply | $3M | 06 Dec 2023 | Singapore, Central Region, Singapore | ||
Entropica Labs | $4M | 07 Nov 2023 | Singapore, Central, Singapore | ||
Engine Biosciences | $27M | 31 Oct 2023 | San Francisco, California, United States |
